Wang, Song
Bager, Cecilie L.
Karsdal, Morten A.
Chondros, Dimitrios
Taverna, Darin
Willumsen, Nicholas http://orcid.org/0000-0002-5207-5173
Clinical trials referenced in this document:
Documents that mention this clinical trial
Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
https://doi.org/10.1186/s12967-021-02701-z
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
https://doi.org/10.1136/gutjnl-2018-316451
Article History
Received: 10 October 2020
Accepted: 8 January 2021
First Online: 21 January 2021
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: SW, DC, and DT are former employees of Halozyme Therapeutics, Inc. and hold shares in the company. CLB, MAK, and NW are employees of Nordic Bioscience and hold shares in the company.